Blog
RSS FeedPosted by Michael Wonder on 10 Jun 2019
The $2.1 million question: what are the medical, ethical implications of the world's priciest drug?
10 June 2019 - With last month’s FDA approval, Zolgensma became the world’s most expensive medication. ...
Posted by Michael Wonder on 23 May 2019
Novartis CEO plans gene therapy price 'far lower' than $4 million to $5 million range
23 May 2019 - Novartis AG’s top executive said on Wednesday it expects to price its gene therapy for spinal ...
Posted by Michael Wonder on 16 May 2019
Instalment payments could be used across gene therapy space, Spark CEO says
16 May 2019 - In a fireside chat at the recently concluded Veeva Summit in Philadelphia, Jeff Marrazzo said payment over ...
Posted by Michael Wonder on 15 May 2019
Drug prices in TV ads: how transparent are they?
15 May 2019 - A website launched by pharmaceutical giant Eli Lilly earlier this year leads with a daunting statement ...
Posted by Michael Wonder on 13 May 2019
Novartis pitches discounts on pricey gene therapy for deadly muscle disorder
11 May 2019 - Novartis is offering price discounts in negotiations with U.S. health insurers on its gene therapy for spinal ...
Posted by Michael Wonder on 13 May 2019
Grandstanding, not real change: why drug prices in TV ads will be confusing and irrelevant
13 May 2019 - In a fit of hubris, President Trump believes he is making drug makers “come clean” by ...
Posted by Michael Wonder on 12 May 2019
Teva and other generic drug makers inflated prices up to 1,000%, State prosecutors say
11 May 2019 - According to a new lawsuit, generic medications including oral antibiotics, blood thinners, cancer drugs, contraceptives and HIV ...
Posted by Michael Wonder on 09 May 2019
Novartis confident of Zolgensma supply, calls $2 million price 'speculation'
8 May 2019 - Novartis is confident it has adequate production capacity for its Zolgensma gene therapy should regulators this ...
Posted by Michael Wonder on 08 May 2019
They were supposed to talk about the patent system driving up drug prices. But most lawmakers got distracted by small tweaks.
7 May 2019 - If there was any hope that Congress might overhaul the way this country doles out the ...
Posted by Michael Wonder on 08 May 2019
A $2 million drug is about to hit the market
8 May 2019 -Insurers, drug makers grapple with new payment models for gene therapies that can cure diseases in one ...
Posted by Michael Wonder on 07 May 2019
In a crafty move, FDA may have found a way to dampen controversy over a $375,000 rare disease drug
6 May 2019 - The FDA just added an unexpected twist to a simmering controversy over a rare disease drug ...
Posted by Michael Wonder on 23 Apr 2019
Pharma lobby nears spending records with drug prices under fire
23 April 2019 - Drug makers, groups disclose first-quarter spending increases. ...
Posted by Michael Wonder on 16 Apr 2019
Evenity (romosozumab-aqqg) now available in the United States for the treatment of osteoporosis in post-menopausal women at high risk for fracture
15 April 2019 - New therapy to cost one-third less than other bone-building agents over full course of therapy. ...
Posted by Michael Wonder on 11 Apr 2019
On rising insulin prices, law maker tells pharma execs: 'Your days are numbered'
10 April 2019 - Lawmakers tensed with frustration, some clenching their jaws, while grilling a panel of pharmacy and pharmaceutical ...
Posted by Michael Wonder on 03 Apr 2019
Overprescribed: high cost isn’t America’s only drug problem
2 April 2019 - The pharmaceutical industry has followed a brilliant two-pronged strategy to maximize its profits: raise prices and ...